Ann: Appendix 4C - quarterly, page-3

Key points from today's Appendix 4C: Purifloh is planning to:

. Treble R&D from $418k in Q2 2018-2019 to $1.25m in Q3

. Slash admin and corporate costs from $654k to $100k

. Run down end-of -quarter cash from $8.6m on Dec 31 to $7.15m on Mar 31

The latest quarterly reveals that PO3 paid top shareholder Dilato Holdings $443k for accounting, administration, rental services and prior accruals in Q2.

It paid $418k to Detroit-based affiliate Somnio Global for R&D.

Somnio seems set to be the main recipient of the ramped up R&D budget.

What will it spend the money on? Tech to destroy TB, eliminate smoke and other pollutants from air, de-bug medical surfaces, clean swimming pools...or all of the above plus more?